rs55991828

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_006904.7(PRKDC):​c.6480C>T​(p.Tyr2160Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00604 in 1,611,100 control chromosomes in the GnomAD database, including 39 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0042 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0062 ( 38 hom. )

Consequence

PRKDC
NM_006904.7 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0970

Publications

10 publications found
Variant links:
Genes affected
PRKDC (HGNC:9413): (protein kinase, DNA-activated, catalytic subunit) This gene encodes the catalytic subunit of the DNA-dependent protein kinase (DNA-PK). It functions with the Ku70/Ku80 heterodimer protein in DNA double strand break repair and recombination. The protein encoded is a member of the PI3/PI4-kinase family.[provided by RefSeq, Jul 2010]
PRKDC Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency due to DNA-PKcs deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 8-47857285-G-A is Benign according to our data. Variant chr8-47857285-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 380483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.097 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 38 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKDCNM_006904.7 linkc.6480C>T p.Tyr2160Tyr synonymous_variant Exon 49 of 86 ENST00000314191.7 NP_008835.5
PRKDCNM_001081640.2 linkc.6480C>T p.Tyr2160Tyr synonymous_variant Exon 49 of 85 NP_001075109.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKDCENST00000314191.7 linkc.6480C>T p.Tyr2160Tyr synonymous_variant Exon 49 of 86 1 NM_006904.7 ENSP00000313420.3
PRKDCENST00000338368.7 linkc.6480C>T p.Tyr2160Tyr synonymous_variant Exon 49 of 85 1 ENSP00000345182.4
PRKDCENST00000697609.1 linkn.641C>T non_coding_transcript_exon_variant Exon 3 of 4
PRKDCENST00000697610.1 linkn.281C>T non_coding_transcript_exon_variant Exon 4 of 4

Frequencies

GnomAD3 genomes
AF:
0.00418
AC:
637
AN:
152232
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00109
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0108
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00254
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00695
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00451
AC:
1105
AN:
245140
AF XY:
0.00433
show subpopulations
Gnomad AFR exome
AF:
0.00156
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.000102
Gnomad EAS exome
AF:
0.0109
Gnomad FIN exome
AF:
0.00368
Gnomad NFE exome
AF:
0.00662
Gnomad OTH exome
AF:
0.00454
GnomAD4 exome
AF:
0.00624
AC:
9097
AN:
1458750
Hom.:
38
Cov.:
30
AF XY:
0.00597
AC XY:
4333
AN XY:
725680
show subpopulations
African (AFR)
AF:
0.00108
AC:
36
AN:
33330
American (AMR)
AF:
0.000981
AC:
43
AN:
43820
Ashkenazi Jewish (ASJ)
AF:
0.0000385
AC:
1
AN:
25996
East Asian (EAS)
AF:
0.00663
AC:
263
AN:
39670
South Asian (SAS)
AF:
0.000724
AC:
62
AN:
85586
European-Finnish (FIN)
AF:
0.00348
AC:
186
AN:
53380
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5758
European-Non Finnish (NFE)
AF:
0.00730
AC:
8105
AN:
1110920
Other (OTH)
AF:
0.00662
AC:
399
AN:
60290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
461
922
1384
1845
2306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00417
AC:
635
AN:
152350
Hom.:
1
Cov.:
33
AF XY:
0.00385
AC XY:
287
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00108
AC:
45
AN:
41590
American (AMR)
AF:
0.00163
AC:
25
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0104
AC:
54
AN:
5186
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4830
European-Finnish (FIN)
AF:
0.00254
AC:
27
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00695
AC:
473
AN:
68032
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
34
68
103
137
171
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00549
Hom.:
9
Bravo
AF:
0.00381
Asia WGS
AF:
0.00837
AC:
29
AN:
3478
EpiCase
AF:
0.00580
EpiControl
AF:
0.00553

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PRKDC: BP4, BP7, BS1, BS2 -

not specified Benign:1
Jul 12, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Severe combined immunodeficiency due to DNA-PKcs deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
0.18
DANN
Benign
0.28
PhyloP100
0.097
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.8
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55991828; hg19: chr8-48769846; COSMIC: COSV58044418; API